Drucker DJ - Search Results

1

Protein engineering strategies for sustained glucagon-like peptide-1 receptor-dependent control of glucose homeostasis.

Picha KM, Cunningham MR, Drucker DJ, Mathur A, Ort T, Scully M, Soderman A, Spinka-Doms T, Stojanovic-Susulic V, Thomas BA, O'Neil KT. Picha KM, et al. Among authors: drucker dj. Diabetes. 2008 Jul;57(7):1926-34. doi: 10.2337/db07-1775. Epub 2008 Apr 21. Diabetes. 2008. PMID: 18426860 Free PMC article.

2

Leptin sensitivity in nonobese glucagon-like peptide I receptor -/- mice.

Scrocchi LA, Brown TJ, Drucker DJ. Scrocchi LA, et al. Among authors: drucker dj. Diabetes. 1997 Dec;46(12):2029-34. doi: 10.2337/diab.46.12.2029. Diabetes. 1997. PMID: 9392491

3

Glucagon-like peptides.

Drucker DJ. Drucker DJ. Diabetes. 1998 Feb;47(2):159-69. doi: 10.2337/diab.47.2.159. Diabetes. 1998. PMID: 9519708 Review.

4

Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.

Scrocchi LA, Marshall BA, Cook SM, Brubaker PL, Drucker DJ. Scrocchi LA, et al. Among authors: drucker dj. Diabetes. 1998 Apr;47(4):632-9. doi: 10.2337/diabetes.47.4.632. Diabetes. 1998. PMID: 9568697

5

Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.

Flamez D, Van Breusegem A, Scrocchi LA, Quartier E, Pipeleers D, Drucker DJ, Schuit F. Flamez D, et al. Among authors: drucker dj. Diabetes. 1998 Apr;47(4):646-52. doi: 10.2337/diabetes.47.4.646. Diabetes. 1998. PMID: 9568699

6

Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.

Pederson RA, Satkunarajah M, McIntosh CH, Scrocchi LA, Flamez D, Schuit F, Drucker DJ, Wheeler MB. Pederson RA, et al. Among authors: drucker dj. Diabetes. 1998 Jul;47(7):1046-52. doi: 10.2337/diabetes.47.7.1046. Diabetes. 1998. PMID: 9648827

7

Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.

Flamez D, Gilon P, Moens K, Van Breusegem A, Delmeire D, Scrocchi LA, Henquin JC, Drucker DJ, Schuit F. Flamez D, et al. Among authors: drucker dj. Diabetes. 1999 Oct;48(10):1979-86. doi: 10.2337/diabetes.48.10.1979. Diabetes. 1999. PMID: 10512362

8

Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.

Stoffers DA, Kieffer TJ, Hussain MA, Drucker DJ, Bonner-Weir S, Habener JF, Egan JM. Stoffers DA, et al. Among authors: drucker dj. Diabetes. 2000 May;49(5):741-8. doi: 10.2337/diabetes.49.5.741. Diabetes. 2000. PMID: 10905482

9

Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.

Scrocchi LA, Hill ME, Saleh J, Perkins B, Drucker DJ. Scrocchi LA, et al. Among authors: drucker dj. Diabetes. 2000 Sep;49(9):1552-60. doi: 10.2337/diabetes.49.9.1552. Diabetes. 2000. PMID: 10969840

10

Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor.

Burcelin R, Da Costa A, Drucker D, Thorens B. Burcelin R, et al. Diabetes. 2001 Aug;50(8):1720-8. doi: 10.2337/diabetes.50.8.1720. Diabetes. 2001. PMID: 11473030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters